Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton`s Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.05.031 (European Urology)

We appreciate the interest from the Princess Margaret group in our report describing poor outcomes following robotic retroperitoneal lymph node dissection (R-RPLND). Their thoughtful approach to offering patients R-RPLND should be commended and perhaps more widely adopted on the basis of our findings [1]. However, the importance of our report remains. Previous small-series publications on robotic technology in testis cancer have not reported any significant adverse outcomes. The patients we described clearly suffered poor outcomes and it is essential that this is included in the literature.